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Internal temporal organisation properly synchronised to the environment is crucial for health
maintenance. This organisation is provided at the cellular level by the molecular clock, a macro-
molecular transcription-based oscillator formed by the clock and the clock-controlled genes that
is present in both central and peripheral tissues. In mammals, melanopsin in light-sensitive reti-
nal ganglion cells plays a considerable role in the synchronisation of the circadian timing system
to the daily light/dark cycle. Melatonin, a hormone synthesised in the pineal gland exclusively at
night and an output of the central clock, has a fundamental role in regulating/timing several
physiological functions, including glucose homeostasis, insulin secretion and energy metabolism.
As such, metabolism is severely impaired after a reduction in melatonin production. Furthermore,
light pollution during the night and shift work schedules can abrogate melatonin synthesis and
impair homeostasis. Chronodisruption during pregnancy has deleterious effects on the health of
progeny, including metabolic, cardiovascular and cognitive dysfunction. Developmental program-
ming by steroids or steroid-mimetic compounds also produces internal circadian disorganisation
that may be a significant factor in the aetiology of fertility disorders such as polycystic ovary
syndrome. Thus, both early and late in life, pernicious alterations of the endogenous temporal
order by environmental factors can disrupt the homeostatic function of the circadian timing
system, leading to pathophysiology and/or disease.
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Time as a variable is frequently neglected when we consider the inter-
action between the organism and the environment. However, life on
Earth means that we are under the geophysical cycles that impose
approximately 12 h of light and approximately 12 h of dark, the old-
est and major environmental time-cue on Earth. Organisms would
have faced natural selection in intervals of opportunity and adversity
that recur with precise and predictable frequencies, generating an
innate temporal programme responsible for circadian oscillations.
These are responsible for orchestrating physiology and behaviour and
allow organisms to anticipate daily environmental changes (1). The
presence of a circadian component in this temporal organisation is
also implied in the way that abnormal entraining cycles often impair
homeostasis. This can be observed from the simplest and most famil-
iar stress imposed by rapid travel across time zones or, more dramati-
cally, from the high frequency of cardiovascular disease, metabolic
syndrome and insomnia observed in workers subjected to night (shift)
work schedules (2–4). We begin our discourse with a discussion of
the molecular basis for circadian oscillations and how robustly con-
served temporal organisation is among organisms. This will lay the
framework for a more comprehensive discussion of how chronodis-
ruption impacts the aetiology of disease in our 24/7 society.
Molecular basis of endogenous biological clocks
Temporal organisation is codified at the genetic level because single
gene mutations can lead to changes in circadian rhythm of activity
or even complete arrhythmia (5). This was first observed in Dro-
sophila melanogaster with mutation of one gene located in chro-
mosome X (6); and, later, in mammals such as the tau-mutant
hamsters (7). Now, we have expanded our view of how evolution
has worked to regulate temporal organisation. A molecular machin-
ery is present in organisms as diverse as cyanobacteria (Synecchus),
fungi (Neurospora), insects (Drosophila), fish (8) and mammals
(9,10). This consists of a set of very-well conserved macromolecules,
known as clock proteins, which function as transcription factors in
a positive and a negative auto-regulatory loop that generates circa-
dian rhythms of clock-controlled gene expression. In mammals, the
proteins CLOCK and BMAL1 (brain and muscle Arnt-like protein 1)
form heterodimers, and enhance the expression of period [Per] and
cryptochrome [Cry] genes (11). PER and CRY dimerise and are phos-
phorylated by casein kinase (12). PER-CRY dimers are then trans-
ported to the cell nucleus where they inhibit their own
transcription (13,14). In parallel, the expression of the transcription
regulators REV-ERBa and RORa is driven by BMAL1:CLOCK and
suppressed by PER and CRY proteins (15). When REV-ERBa is
absent, Bmal1 gene (and probably Clock) is released from its inhibi-
tion, starting a new circadian cycle (16). REVERBa and RORa are
not core components of the transcriptional oscillator but act as a
‘stabilising loop’ to facilitate robustness within the core clock
machinery.
Entrainment of the circadian timing system
Among the environmental clues, light/dark cycles appear to be one
of the most important daily synchronisers or ‘Zeitgebers’ (as used
by Aschoff) of endogenous circadian oscillators (17). When one
oscillator is coupled to and driven by another, it assumes its period;
this coupling guarantees changes of the circadian period of an
organism to precisely 24 h and establishes a functional phase-rela-
tionship between them (1). In insects, mollusks, reptiles, birds and
mammals, there is a clear association between endogenous oscilla-
tors and photoreceptors, stressing the predominance of cycles of
light in the entrainment of circadian rhythms (18). This relationship
may indicate a co-evolution of these systems (perception of light
and endogenous circadian clock) to the same selective pressure.
This is the basis for the evolution of the ‘escape from light’ hypoth-
esis: high temperatures found in the light phase of the day would
have been hazardous for the stability of enzymes and physiological
processes, as much as ultraviolet radiation would have been for
DNA structure (19). This idea the of co-evolution of these systems
has been confirmed by the recent study of Shen et al. (20), who
demonstrated that rhodopsin, a photopigment found in visual pho-
toreceptors, is required for temperature discrimination in D. mela-
nogaster. Furthermore, the photopigment melanopsin, expressed in
intrinsic light sensitive cells of the mammalian retina, also appears
to participate in this response. Expression of melanopsin in rhodop-
sin-null mutants effectively rescues temperature discrimination (20).
By contrast to basal vertebrates, which possess extra-ocular pho-
toreceptors (pineal complex and deep brain photoreceptors) (21),
mammals rely only on their eyes for light perception (22). Surpris-
ingly, classical photoreceptors for image forming visual function
(i.e. the rods and cones) are not essential for light-entrainment
(23). A subset of retinal ganglion cells, referred to as intrinsically-
photosensitive retinal ganglion cells (ipRGC), are capable of captur-
ing light radiation (24) and conveying this information to the sup-
rachiasmatic nucleus (SCN) (25). IpRGCs express the photopigment
melanopsin (24), which was first cloned in Xenopus laevis melano-
phores (26) and is now known to be present in the retina of all
vertebrates, including humans (27). The melanopsin positive ipRGCs
are fundamental for light entrainment of the circadian system
(25,28). Visual photoreceptors, although not essential, have a per-
missive effect on this process (29).
Peripheral clocks
In the classic view of biological clock functioning, a light signal
detected either by retinal photoreceptors or by extra-retinal photo-
receptors is transmitted to a central oscillator (the SCN in mam-
mals) and, subsequently, temporal information is disseminated to
the remainder of the organism by the output of the central oscilla-
tor (30). However, Plautz et al. (31) elegantly demonstrated that
Per1 is rhythmically expressed in the legs, wings and antennas from
a transgenic fly expressing the enzyme luciferase under the control
of Per1 gene promoter. This oscillatory profile is synchronised by
light/dark cycles, suggesting that these tissues are able to indepen-
dently detect light and translate this signal to the molecular clock.
These results point to the existence of multiple oscillators, an idea
suggested long ago by Aschoff from his study in humans, in which
sleep–wake cycles can be dissociated from body temperature oscil-
lations (32). In agreement with this decentralised view of the bio-
logical clock, the core molecular clock machinery is expressed in
almost all cells and tissues (33,34). Robust cell-autonomous
rhythms of clock gene and clock-controlled gene expression have
been detected in isolated cell cultures from both mammals (35,36)
and non-mammalian vertebrates (37–40). Together, these data
strengthen the notion that, in addition to a central clock, there are
multiple circadian oscillators throughout the mammalian body col-
lectively referred to as peripheral clocks.
The identification of the central clock in mammals was based in
large part on SCN transplant experiments. Transplants of this region
reinstated rhythms in SCN lesioned animals (41,42) and Clock or
Cry1-2 double mutant-mice (43,44). Furthermore, SCN lesions abol-
ish rhythmic Per2 gene expression in rat peripheral tissues (45).
These results suggest that peripheral clocks are dependent or ‘slave’
to the SCN for the appearance of circadian oscillations (46). This
notion was supported by the fact that the SCN generates its own
rhythm and isolated SCN explants show sustained rhythms for
more than 30 cycles, whereas peripheral clocks were attenuated
after a few days in culture (33). This assertion was subsequently
rejected based on the independence of the oscillator in many
peripheral tissues (34,36,47,48). Furthermore, disruption of clock
gene function in the liver abolishes the circadian regulation of
clock-controlled genes (49,50), reinforcing the idea that peripheral
tissues possess their own rhythm-generating machinery. It was thus
determined that cultured organs from SCN lesioned mice retain
their rhythmic expression of clock genes when isolated, although
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with different phases from the intact animal, indicating the loss of
synchronisation (34). It is now known that the rhythm attenuation
of cultured cells (33,51) is a function of phase coherence among
individual isolated cells. That is, when clock gene rhythms are anal-
ysed in populations of uncoupled cells, although clock gene oscilla-
tions persist in each cell, the rhythm appears damped because each
cell oscillates in its own phase. This was demonstrated in elegant
studies by Welsh et al. (36) in rat fibroblasts and by Carr and Whit-
more (52) in a zebrafish embryonic cell line. These data indicate
that circadian organisation begins at the cellular level and may be
functionally dependent on cell-to-cell communication within a net-
work of oscillators in each tissue.
The organisation of circadian timing, from interlocked loops of
gene expression to coordinated timing of cell and tissue physiology,
represents a sophisticated and precise system of temporal order.
Understanding the basic mechanism and organisation of the circa-
dian timing system is critical to advancing exploration of its com-
plex role in metabolism, endocrine and neuroendocrine physiology.
Disturbances to this program can often result in pathophysiology
and disease.
Environment, biological rhythms, melatonin and energy
metabolism
The circadian temporal structure of mammalian organism divides
the 24-h day into one period of activity and another of rest, defin-
ing the daily rest/activity cycle. All physiological functions are
accordingly distributed to be the effective support for the proper
articulation of all the behavioural expressions typical of the rest/
activity cycle. As an intrinsic part of this circadian temporal struc-
ture, energy metabolism is temporally distributed to maintain
energy balance and to synchronise metabolism with the rest/activity
cycle. In this way, the acquisition of energy through feeding is
restricted to the activity phase, whereas fasting, or burning of the
stored energy, is associated with the rest phase of the daily cycle.
An exception to this distribution of the physiological functions syn-
chronised to the rest/activity cycle is the synthesis and secretion of
pineal melatonin. Pineal melatonin production is always allocated
to the dark or night portion of the day, no matter what the
behavioural distribution of the activity/rest cycle (i.e. in either diur-
nal or nocturnal species).
Melatonin is considered to be a potent chronobiotic because it is
the interface between the light/dark environmental cycle and the
organism so that its plasma profile is able to indicate whether it is
light or day outside, by its absence or negligible blood concentra-
tion, or whether it is night, by its presence or high blood concen-
tration (53). In addition, the neuroendocrine system that regulates
the synthesis of pineal melatonin is such that the nocturnal plasma
melatonin secretory episode reflects exactly the duration of the
dark phase of the day or, in other words, the duration of the pho-
toperiod or the season of the year (53). The conspicuousness of
melatonin production and its strict association with the dark phase
of the light/dark daily cycle is such that melatonin is an important
element in the setting of the circadian temporal order. Thus, it is
no surprise that melatonin is able to regulate most of the physio-
logical systems in the mammalian organism such as the sleep/wake
cycle, reproduction, the cardiovascular system and blood pressure,
including energy metabolism and energy balance (54).
Melatonin regulates energy intake [feeding (55–57)] so that pine-
alectomised or aged animals (that have no or sharply reduced mel-
atonin production, respectively) display increased food intake that is
restored to normal when the animals are treated with melatonin on
a daily basis [56,57]. In addition, melatonin promotes the mainte-
nance of brown adipose tissue and the browning of white adipose
tissue and also activates the thermogenic function in these tissues
promoting energy expenditure (58). Thus, melatonin is able to regu-
late energy balance and body weight such that an absence or
reduction in melatonin production induces obesity, whereas melato-
nin treatment is able to reduce body weight (56,57).
One of the main roles for melatonin in regulating energy metab-
olism is its synergism with insulin signalling (54). Melatonin, acting
through its membrane receptors, is able to phosphorylate the insu-
lin receptor and potentiate the insulin signalling cascade (59). In
addition, melatonin promotes the synthesis of glucose transporter
GLUT4 in muscle and adipose tissues (60,61). It should be stressed
that the daily distribution of energy metabolism is dependent on
the rhythmic production of melatonin because melatonin deficiency
causes increased hepatic gluconeogenesis and hepatic insulin resis-
tance during the active phase of the rest/activity cycle (62). This is
largely detrimental because both metabolic processes should peak
during the fasting period and not during the time of feeding. The
absence or reduction of melatonin production leads to a metabolic
scenario that involves insulin resistance, glucose intolerance, dyslip-
idaemia and obesity (60). This metabolic dysfunction is completely
restored if the animal is treated with melatonin (61). As a corollary,
metabolic diseases such as diabetes (either type 1 or type 2 diabe-
tes) lead to a reduction in melatonin production aggravating the
metabolic picture (Amaral et al., submitted).
It is worth noting that light during the night and the nocturnal
use of electronic devices with LED screens emitting light in the
blue–green wavelength is one of the most powerful blockers of
melatonin synthesis through the activation of the melanopsinergic
retinal system projecting to the hypothalamus (28). The use of such
LED screen technology, so predominant in our contemporary soci-
ety, may reduce melatonin production and, as a consequence, con-
tribute to the appearance of insulin resistance, glucose intolerance
and obesity.
Impact of gestational chronodisruption on foetal and
postnatal physiology
Epidemiological and experimental evidence suggests that there are
deleterious effects for human health with respect to working under
‘light-at-night’ conditions. Given that, in our 24/7 society, shift
work affects approximately 20–25% of the workforce, even a mod-
est detrimental impact upon health may have important public
health implications (63). Data from the International Labor Organi-
zation indicate that 160 million workers are becoming ill because of
workplace hazards; with approximately 36 million of them being
subjected to chronodisruption. The term chronodisruption was
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coined by Reiter and colleagues in 2003, to define ‘a relevant dis-
turbance of the circadian organization of physiology, endocrinology,
metabolism and behavior’ (64); which is characterised by plasma
melatonin suppression under ‘lights on’ conditions (65). In 2007,
the International Agency for Research on Cancer reclassified work-
ing at night from a possible to a probable human carcinogen, with
the proof of principle being an increased prevalence of breast can-
cer in nurses and flight attendants (66). Recently, a link between
shift work and type 2 diabetes has been inferred from statistical
analyses of a large nurses cohort; whereas the poor diet frequently
observed in shift workers was suggested as one weight gain factor
predisposing to diabetes (63,67). Further epidemiological evidence
together with studies of clock gene mutants also indicates the
adverse effects of shift work on adult physiology: an increased risk
of chronic diseases such as cardiovascular, metabolic and gastroin-
testinal disorders, some types of cancer and mental disorders
including depression (68–70).
Regarding the effects of chronodisruption on pregnancy out-
come, an increased risk of miscarriage, preterm delivery and low
birth weight have been consistently reported in female shift work-
ers (71–73); it is notable that both factors are strong predictors of
chronic disease later in life (74). Against this background, a number
of studies have established a relationship between antenatal delete-
rious environments (e.g. foetal undernutrition and/or hypoxia) and
the onset of adult diseases including hypertension, coronary heart
disease, stroke, as well as metabolic and neurological disorders (74).
It is conceivable that, in the physiological context of pregnancy,
both the maternal and developing foetal circadian system may
become targets of chronodisruption. Indeed, several organs appear to
operate as peripheral oscillators in foetuses from different species,
despite their SCN not yet being a functional master clock (75). Indeed,
we have recently identified day/night changes in clock gene expres-
sion in the foetal rat heart, hippocampus, pineal and adrenal already
entrained to the light/dark (LD) cycle at 18 days of gestation (75).
The possibility of foetal rhythms being entrained by transplacental
and/or biophysical cues is in line with our recent study in primates
on the effects of constant light (LL) exposure during late gestation on
rhythms of body temperature in newborns (76). This study showed
that gestational chronodisruption affected newborn body tempera-
ture rhythms. This rhythm was entrained in control LD newborns,
whereas LL newborns showed a random distribution of temperature
acrophase over 24 h (i.e. a free-running circadian period). In mice,
the perinatal photoperiod was shown to have a long-lasting effect
on the molecular clockwork in the SCN and on neurobehavioural dis-
orders (77). In rats, Varcoe and colleagues exposed dams to chronic
phase shifts (CPS) in their photoperiod every 3–4 days throughout
gestation and the first week after birth. The offspring of CPS rats dis-
played poor glucose tolerance and increased insulin secretion in
response to an i.p. glucose tolerance test (78). Interestingly, this was
also associated with increased anxiety in the CPS rat, supporting an
influence of circadian disruption on deep brain structures involved in
depression, including the hippocampus (78). Further experiments in
murine models include a recent report using mice subjected to
repeated shifting of the LD cycle, which showed both increased non-
productive mating and decreased term pregnancies (79).
We recently characterised the foetal rat adrenal gland as a
strong peripheral clock entrained by maternal melatonin (80). In
further experiments, exposure of pregnant rats to LL (along the sec-
ond half of gestation) induced intrauterine growth retardation, as
well as changes in the relative expression of clockwork and steroi-
dogenic genes and a reduced content of corticosterone (which in
turn did not have a circadian rhythm) in the foetal adrenal, with
no change in maternal plasma corticosterone (81). On the other
hand, in the LD foetal rat hippocampus, we found oscillatory
expression of different clock and clock-controlled genes, which was
suppressed under LL conditions. Strikingly, we also found a signifi-
cant spatial memory deficit in adult offspring that had been ges-
tated under LL conditions (82). Of note, all these changes were
reversed when the LL mother received melatonin during the subjec-
tive night, supporting the idea that the maternal plasma melatonin
rhythm may drive the foetal circadian system (81,82).
We compared the LL and LD foetal heart using a microarray-
based functional genomics approach (83). Differential expression
was found for 383 transcripts in the LL foetal heart; with 42 dis-
playing a ≥ 1.5-fold change in expression. Deregulation of several
markers of cardiovascular disease may contribute to the observed
alteration of diverse gene networks in the LL foetal heart, including
local steroidogenesis, vascular calcification, cardiac hypertrophy,
stenosis and necrosis/cell death. Indeed, gestational chronodisrup-
tion markedly inhibited the transcription not only of enzymes
involved in cardiac steroid hormone synthesis (Hsd3b1, Cyp21a1,
Star, Cyp11a1 and Cyp11b1), but also of vascular calcification-
related genes (Gas6 and Mgp). Transcription of several additional
markers of cardiovascular disease was either up-regulated (Mdk,
Cited1 and Slc2a1) or down-regulated (Adra1a and Lrrc10) in the
foetal heart by gestational chronodisruption (83). Integrated analy-
sis of significant pathway enrichment for pathological processes in
the LL foetal heart is shown in Fig. 1. In addition, several gene
ontology categories related to DNA integrity were over-represented
(such as DNA metabolism, function and maintenance), including a
2.1-fold increase of Hmga1 mRNA, which encodes for an abundant
architectural transcription factor. At the epigenetic level, microRNA
analysis revealed up-regulation of miRNAs 218-1 and 501 and con-
current down-regulation of their validated target genes (83).
Among them, the nuclear factor, interleukin 3 regulated (Nfil3) gene
appears to be under the negative control of both miRNA 218-1 and
miRNA 501. Nfil3 is a transcription factor that binds to the pro-
moter region of interleukin-3. Regarding the remaining transcripts
potentially targeted for degradation by increased miRNA 218-1
under gestational chronodisruption, Sarcalumenin (Srl) and Xin
repeat-containing protein 2 (Xirp2 or Xinb) have been reported as
being relevant for cardiac development and function (83).
The alteration in the transcription level of several disease markers
in the foetal heart subjected to chronodisruption prompted us to
examine any long-term effect on cardiomyocyte or whole heart
morphology. In 90-day-old rats that had been gestated under con-
stant light, we observed an altered left ventricle phenotype, as
defined by an increased cardiomyocyte nuclear and cell diameter, as
well as increased wall thickness, accompanied by a reduced cavity
area (83). Next, we investigated whether the early onset of altered
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transcription of cardiovascular disease markers may persist into
adulthood for 10 selected transcripts in the LL versus LD heart of
foetal and adult offspring. A lasting and significant alteration was
found only for Kcnip2 mRNA, which was decreased at both develop-
mental stages. KCNIP2 is a calcium-binding protein acting as a sub-
unit of the voltage gated potassium Kv4 channel complex, which is
crucial for the conduction system to regulate calcium-dependent A-
type currents. This result is particularly relevant given that studies in
humans and mice have linked mutation of the Kcnip2 gene with ar-
rhythmogenesis and heart failure. Moreover, there is solid evidence
accounting for a significant decrease of Kcnip2 gene expression in
hypertrophy, particularly in the left ventricle wall (83).
In conclusion, recent findings in murine models of gestational
chronodisruption indicate persistent metabolic, cognitive and car-
diovascular alterations in the adult offspring. These results support
epidemiological data obtained in humans, suggesting that circadian
misalignment during gestation may have detrimental consequences
for pregnancy outcome. Collectively, these data raise challenging
questions about the consequences of shift work during pregnancy.
Chronodisruption and fertility: a role for the timing
system in reproductive pathophysiology
In mammals, reproductive physiology and metabolism are both
directly and indirectly regulated by the circadian timing system
(2,3,84). Circadian disruption as a result of chronic sleep distur-
bances, shift-work or persistent transmeridian travel (jet-lag) can
produce irregular menstrual cycles in women (85). Furthermore,
genetic or environmental manipulations that alter or abolish clock
function have significant negative impacts on both fertility and
metabolic homeostasis (2,78,86,87). Central circadian pacemakers,
including the SCN, play established and well-described roles in
female reproductive physiology (88–90). Recently, cellular clocks
outside the brain, including those in the pituitary gland, oviduct,
uterine and ovarian cells, have been implicated in reproductive
function (91). It has been suggested that the clock in the ovary
may play a significant role in the timing of ovulation, steroid hor-
mone synthesis and follicular maturation (92–95). Furthermore,
clocks in the female reproductive tract have been implicated in the
processes of embryo maturation, implantation and parturition (96–
101). Together, these data suggest that circadian clock function at
the cellular level appears to be critical for normal reproductive
physiology.
Fertility disorders represent a considerable health issue world-
wide, with fertility rates dropping by almost 45% in the USA alone
in the past 40 years (102,103). Although some of this decline in
fertility can be related to socioeconomic factors, the impacts of
environmental contaminants and metabolic disease are considerable
(102–106). Early developmental exposure to steroid-mimetic endo-
crine disrupting compounds (e.g. bisphenol A), maternal obesity and
endocrinopathies such as polycystic ovary syndrome (PCOS) have
been linked to infertility and adverse metabolic function (107–109).
PCOS is particularly common and devastating, affecting approxi-
mately 10% of unselected women during their childbearing years
(110). Despite the frequency of diagnosis and the intense focus of
scientific research, the aetiology of the disease remains largely
unknown (111). The primary symptoms of the disease include
abnormal ovarian physiology, specifically anovulation and a poly-
cystic ovarian morphology (112,113). The disease is often co-morbid
with a metabolic syndrome characterised by hyperinsulinaemia,
obesity, and an increased risk of type-2 diabetes and cardiovascular
disease (112–114). Developmental programming as a result of
excess androgen exposure in utero is considered to be a significant
factor (114–116). In several animal models, prenatal androgenisa-
tion produces a PCOS phenotype in adult female offspring
(106,117). Much of the reproductive dysfunction of PCOS, from
altered gonadotrophin secretion to anovulation, has been directly or
indirectly linked to excess foetal or pubertal androgen (118–120).
It is widely considered that synchronisation among central and
peripheral oscillators (e.g. SCN, ovary, liver, etc.) is a fundamental
property of physiological homeostasis (11). Thus, internal circadian
organisation is broadly defined as the coordinated and synchronised
timing of central and peripheral clocks, as well as the timing of
each tissue clock relative to the environment (Fig. 2A, top). A
decline in internal circadian organisation, coincident with, and
potentially caused by chronodisruption (as seen during chronic jet-
lag, rotating shift-work and non-24-h entrainment), can lead to
health issues, including pre-diabetes, cancer and cardiovascular dis-
ease (121–124). Although chronodisruption is most commonly asso-
ciated with nonstandard lighting conditions and altered sleep–wake
Threshold
Cardiac pulmonary embolism
Cardiac hypertrophy
Cardiac stenosis
Cardiac necrosis/cell death
Cardiac arrythmia
Cardiac damage
Cardiac degeneration
Cardiac enlargement
Tachycardia
0 1
–Log (P-value)
2 3
Fig. 1. Impact of gestational chronodisruption on foetal cardiac genomics.
Identification of over-represented pathways by functional genomics analysis
of foetal rat heart gestated under constant light (LL) relative to control pho-
toperiod (LD). RNA isolated from foetal heart at 18 days of gestation was
subjected to microarray analysis (Affymetrix platform for 28 000 genes; Af-
fymetrix, Santa Clara, CA, USA). Significant differential expression was found
for 383 transcripts in LL relative to LD foetal heart (for details, see text).
Integrated transcriptional changes were assessed using INGENUITY PATHWAY
ANALYSIS (IPA) software (Qiagen, Valencia, CA, USA). IPA was set to pinpoint
pathological processes predictably affected by the interaction of the whole
set of differentially expressed genes in the foetal rat heart subjected to the
LL condition. The threshold (blue) line indicates P = 0.05. A similar set of
results was reported by Galdames et al. (83).
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cycles (e.g. shift-work), other factors may have an equally dramatic
impact upon internal circadian organisation (125). We have deter-
mined that exposure to excess androgen (hyperandrogenaemia)
during foetal development [prenatal androgenisation (PNA)] disrupts
reproductive function and causes a considerable decline in internal
circadian organisation (Fig. 2B). Developmental programming by
excess androgen alters reproductive function and metabolism in
adult female offspring, producing a rodent model of the PCOS
(117). Measurement of peak PERIOD2::LUCIFERASE expression in the
SCN and peripheral tissues from PNA transgenic mice reveals a sig-
nificantly reduced phase synchrony among peripheral oscillators,
with the most pronounced effects apparent in tissues of the hypo-
thalamic-pituitary-ovarian (HPO) axis and the liver. The reduction in
phase-coherence among oscillators is striking given that these mice
remained under a standard 12 : 12 h light/dark cycle and appear
to have completely normal SCN phase (Fig. 2B). The observed
decline in circadian organisation is quite similar to the established
effect of SCN lesions on internal circadian organisation (126). This
is notable because it was recently shown that lesions of the SCN
produce insulin resistance and metabolic disease in mice, a meta-
bolic phenotype similar to that of PCOS animals (127). Although
the number of explants in the control group is smaller, relative to
the PNA mice, we failed to detect a single tissue from control mice
peaking more than 4–5 h away from the mean phase. This is in
dramatic contrast to PNA mice, in which we see several tissues
peaking during the relative day, in some cases 8–12 h out of phase
Control
SCN
WAT
Oviduct
Follicle
Pituitary
Cornea
Lung
Liver
0
PNA
4 8 12 16 20 24
Relative ZT (h)
Relative ZT (h)
Kidney
SCN
WAT
Oviduct
Follicle
Pituitary
Lung
Liver
0
06.00 h06.00 h 18.00 h
4 8 12 16 20 24 4
Kidney
Normal internal circadian organization
Internal circadian disruption
(A) (B)
Fig. 2. Chronodisruption and fertility: impact of androgen-dependent developmental programming on the circadian timing system. (A) Synchronisation among
central and peripheral oscillators [e.g. suprachiasmatic nucleus (SCN), ovary] is a fundamental property of physiological homeostasis. Coordination of gene
expression and cellular physiology among oscillators and phase synchrony between oscillators and the environment (e.g. entrainment) are critical features of
internal circadian organisation. (B) In control animals, phase synchrony among central and peripheral oscillators of both the hypothalamic-pituitary-ovarian
and metabolic axes is robust and cohesive (n = 2–5 explants/tissue). After prenatal androgenisation, phase distribution within several tissues, including follicles
and liver, increases dramatically, resulting in considerable internal circadian disruption (n = 8–12 explants/tissue). This decline in circadian organisation is coin-
cident with abnormal reproductive cycles, a hallmark of polycystic ovary syndrome. (B) Each symbol represents a tissue from a different animal and tissues
from the same animal are connected by a solid line. The peak phase of PER2::LUC expression is plotted as a function of ‘relative Zeitgeber Time (ZT)’ where
ZT0 = the time of lights on for the animal before euthanasia. The 12-h dark phase is shaded in grey. PNA, prenatal androgenisation; WAT, white adipose tissue.
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with other tissues from the same animal. This result is parallel to
our finding in rats exposed to excess androgen during late adoles-
cence and puberty (125). It is also worth noting that the impact of
PNA on internal circadian organisation is not ubiquitous and may
correlate with the degree of hyperandrogaemia, metabolic disease
and/or reproductive dysfunction in each animal. It will be critical to
establish the strength of correlation between the severity of disease
progression and the degree of internal circadian disorganisation.
Nonetheless, these data suggest a direct influence of androgen
on target oscillators in the HPO axis and/or disruption of the sys-
temic cues needed to mediate adequate synchronisation among
peripheral oscillators (30). How might androgens influence the tim-
ing of the circadian clock? There is considerable evidence linking
androgen signalling to circadian clock function in mammals. Andro-
gens affect circadian rhythms of locomotor activity (128–132) and
can directly affect clock gene expression in prostate cancer cells
(133). These data reveal that PER1 interacts with the androgen
receptor (AR), PER1 expression is altered by androgen exposure and
PER1 directly suppresses the transactivation of AR gene expression
(133). Our preliminary data suggest that androgen may alter the
period of the clock in target tissues, such as the ovarian granulosa
cell, in a tissue-dependent manner. Although the site of the effects
of androgen is unclear, the fact that androgens can alter the timing
of the clock in multiple cell types and under various conditions
suggests that developmental programming by androgen may medi-
ate its affects in part by its impact upon the circadian timing sys-
tem. A more comprehensive and focused examination of the
interaction between androgen signalling and the clock, particularly
as it relates to diseases of androgen excess, will provide additional
insights and perhaps lead to new therapeutic targets for the treat-
ment of common fertility disorders such as PCOS.
Summary and conclusions
The circadian timing system is a complex and integral regulator of
physiological homeostasis, particularly in the endocrine and neuro-
endocrine systems. The timing system is evolutionarily conserved,
with distinct mechanisms of parallel function across phylum. In
mammals, the central pacemaker in the SCN receives direct retinal
input and synchronises or entrains central and peripheral clocks to
the external environment. The means of this synchronisation are
multifaceted and integrative; incorporating both hormonal (e.g.
glucocorticoids, melatonin) and neural cues (e.g. sympathetic
nerves). Disruption of temporal order within the circadian system,
or chronodisruption, as a result of abrupt and/or chronic changes
in lighting condition (i.e. shiftwork, jet-lag) can have devastating
impacts on physiology. Chronodisruption is associated with an
increased risk of cancer, metabolic, cardiovascular and mental dis-
ease. As an output of the central clock, melatonin is a potent chro-
nobiotic that modulates a number of physiological functions,
including energy metabolism. A decline or even absence of normal
melatonin secretion as a result of ‘light at night’ and/or shift work
schedules is a salient feature of chronodisruption. Chronodisruption
during pregnancy has considerable effect on gene expression (both
clock and clock-controlled genes) with negative consequences for
the life of the progeny, including persistent metabolic, cognitive
and cardiovascular dysfunction. Although aberrant light exposure
(e.g. light at night) is the most established and well-characterised
form of chronodisruption, other environmental influences can also
produce circadian disruption. As an example, steroid hormone-
dependent developmental programming produces a polycystic ovary
and reduces fertility with a parallel decline in internal circadian
organisation. Thus, chronodisruption may be a common feature of
fertility and metabolic diseases arising from foetal exposure to dis-
ruptive lighting conditions or an irregular hormonal milieu. Life in a
24/7 society together with the evidence discussed in the present
review emphasises that there is the need for a continued and pro-
found discussion regarding chronodisruption and its consequences
for human health.
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